| scholarly article | Q13442814 |
| P2093 | author name string | S Nimmannitya | |
| F A Ennis | |||
| I Kurane | |||
| A Nisalak | |||
| A Meager | |||
| B L Innis | |||
| C Hoke | |||
| P2860 | cites work | Immune interferon induces the receptor for monomeric IgG1 on human monocytic and myeloid cells | Q24683253 |
| Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g | Q26778365 | ||
| Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody | Q27485050 | ||
| Dengue viruses and mononuclear phagocytes. II. Identity of blood and tissue leukocytes supporting in vitro infection | Q27485051 | ||
| Gamma interferon augments Fc gamma receptor-mediated dengue virus infection of human monocytic cells | Q27486876 | ||
| Lysis of dengue virus-infected cells by natural cell-mediated cytotoxicity and antibody-dependent cell-mediated cytotoxicity | Q27486907 | ||
| A prospective study of dengue infections in Bangkok | Q28296365 | ||
| Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak | Q29619424 | ||
| In Vivo Enhancement of Dengue Virus Infection in Rhesus Monkeys by Passively Transferred Antibody | Q29619712 | ||
| Evidence That Maternal Dengue Antibodies Are Important in the Development of Dengue Hemorrhagic Fever in Infants | Q29620637 | ||
| Recombinant immune interferon increases immunoglobulin G Fc receptors on cultured human mononuclear phagocytes | Q33821962 | ||
| Evolutionary conservation of surface molecules that distinguish T lymphocyte helper/inducer and cytotoxic/suppressor subpopulations in mouse and man | Q36344425 | ||
| Antibodies to membrane structures that distinguish suppressor/cytotoxic and helper T lymphocyte subpopulations block the mixed leukocyte reaction in man | Q36345324 | ||
| Immune interferon produced to high levels by antigenic stimulation of human lymphocytes with influenza virus | Q36345923 | ||
| Flavivirus replication strategy | Q39509590 | ||
| Interferons with Special Emphasis on the Immune System | Q40108361 | ||
| The Alexander D. Langmuir Lecture. The pathogenesis of dengue. Molecular epidemiology in infectious disease | Q40126879 | ||
| The nucleotide sequence of dengue type 4 virus: analysis of genes coding for nonstructural proteins | Q40795113 | ||
| Monoclonal antibodies against dengue 2 virus E-glycoprotein protect mice against lethal dengue infection | Q40798801 | ||
| Protection of mice against dengue 2 virus encephalitis by immunization with the dengue 2 virus non-structural glycoprotein NS1. | Q40798835 | ||
| Cloning full-length dengue type 4 viral DNA sequences: analysis of genes coding for structural proteins | Q40803999 | ||
| Characterization with monoclonal antibodies of human lymphocytes active in natural killing and antibody-dependent cell-mediated cytotoxicity of dengue virus-infected cells | Q40807020 | ||
| Detection of hybridomas secreting monoclonal antibodies to human gamma interferon using a rapid screening technique and specificity of certain monoclonal antibodies to gamma interferon | Q42822801 | ||
| Characterization of a human B lymphocyte-specific antigen. | Q44191670 | ||
| Human cytomegalovirus-specific cytotoxic T lymphocytes: requirements forin vitro generation and specificity | Q44672031 | ||
| Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. I. Lysis restricted by HLA class II MB and DR antigens. | Q45795144 | ||
| Influenza virus-specific human cytotoxic T cell clones: heterogeneity in antigenic specificity and restriction by class II MHC products | Q45804037 | ||
| Measles virus-specific T4+ human cytotoxic T cell clones are restricted by class II HLA antigens | Q45804361 | ||
| Human interferon alpha and gamma production by lymphocytes during the generation of influenza virus-specific cytotoxic T lymphocytes | Q45834036 | ||
| Generation of phenotypically different T cell populations by cell-free or cell-bound preparations of varicella zoster virus | Q45835943 | ||
| The isolation and characterization of the human suppressor inducer T cell subset | Q67275344 | ||
| The isolation and characterization of the human helper inducer T cell subset | Q67283653 | ||
| Epitope localization of a monoclonal antibody, LO-22, with broad specificity for interferon-alpha subtypes | Q68991883 | ||
| Measles-specific T cell clones derived from a twin with multiple sclerosis: genetic restriction studies | Q69380749 | ||
| Leu-3+ T cells produce gamma-interferon in patients with recurrent herpes labialis | Q70459367 | ||
| A human natural killer cell-associated antigen defined by monoclonal antibody anti-Leu (NKP-15): functional and two-color flow cytometry analysis | Q71004745 | ||
| Spontaneous production of interferon-gamma in adult and newborn humans | Q72720607 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Dengue virus | Q476209 |
| P304 | page(s) | 506-513 | |
| P577 | publication date | 1989-02-01 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | Human T cell responses to dengue virus antigens. Proliferative responses and interferon gamma production | |
| P478 | volume | 83 |
| Q40546528 | A Blunted Blood Plasmacytoid Dendritic Cell Response to an Acute Systemic Viral Infection Is Associated with Increased Disease Severity |
| Q64986771 | A Stillborn Multiple Organs' Investigation from a Maternal DENV-4 Infection: Histopathological and Inflammatory Mediators Characterization. |
| Q27473138 | A live, attenuated recombinant West Nile virus vaccine |
| Q27485111 | A single nine-amino acid peptide induces virus-specific, CD8+ human cytotoxic T lymphocyte clones of heterogeneous serotype specificities |
| Q39385904 | Activation of Dengue Virus-Specific T Cells Modulates Vascular Endothelial Growth Factor Receptor 2 Expression |
| Q34207386 | Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-gamma in sera of children with dengue |
| Q27469336 | Analysis of murine CD8(+) T-cell clones specific for the Dengue virus NS3 protein: flavivirus cross-reactivity and influence of infecting serotype |
| Q35616815 | Antigenic structure of flavivirus proteins |
| Q37425963 | Biomarkers in Japanese encephalitis: a review |
| Q33696548 | Bystander T cells in human immune responses to dengue antigens |
| Q27469356 | Bystander target cell lysis and cytokine production by dengue virus-specific human CD4(+) cytotoxic T-lymphocyte clones |
| Q40885343 | CD4(+) T-cell responses to bovine viral diarrhoea virus in cattle |
| Q40410592 | Cell-mediated immunity induced by chimeric tetravalent dengue vaccine in naive or flavivirus-primed subjects |
| Q38121757 | Challenges for the formulation of a universal vaccine against dengue. |
| Q61803857 | Cytokine Signature Associated with Disease Severity in Dengue |
| Q27486071 | Definition of an HLA-DPw2-restricted epitope on NS3, recognized by a dengue virus serotype-cross-reactive human CD4+ CD8- cytotoxic T-cell clone |
| Q40384839 | Deletion of the C-terminal region of dengue virus nonstructural protein 1 (NS1) abolishes anti-NS1-mediated platelet dysfunction and bleeding tendency |
| Q61807015 | Dendritic Cell Targeting Using a DNA Vaccine Induces Specific Antibodies and CD4 T Cells to the Dengue Virus Envelope Protein Domain III |
| Q27477895 | Dengue viral infections |
| Q24673736 | Dengue virus selectively induces human mast cell chemokine production |
| Q27486631 | Dengue virus-specific cross-reactive CD8+ human cytotoxic T lymphocytes |
| Q27486068 | Dengue virus-specific human CD4+ T-lymphocyte responses in a recipient of an experimental live-attenuated dengue virus type 1 vaccine: bulk culture proliferation, clonal analysis, and precursor frequency determination |
| Q27485093 | Dengue virus-specific human T cell clones. Serotype crossreactive proliferation, interferon gamma production, and cytotoxic activity |
| Q27486616 | Dengue virus-specific murine T-lymphocyte proliferation: serotype specificity and response to recombinant viral proteins |
| Q27486185 | Dengue virus-specific, human CD4+ CD8- cytotoxic T-cell clones: multiple patterns of virus cross-reactivity recognized by NS3-specific T-cell clones |
| Q39117650 | Determination of antibody concentration as the main parameter in a dengue virus antibody-dependent enhancement assay using FcγR-expressing BHK cells |
| Q34259867 | Differential in vivo clearance and response to secondary heterologous infections by H2(b)-restricted dengue virus-specific CD8+ T cells |
| Q34518791 | Differential targeting of viral components by CD4+ versus CD8+ T lymphocytes in dengue virus infection. |
| Q37360615 | Dominant recognition by human CD8+ cytotoxic T lymphocytes of dengue virus nonstructural proteins NS3 and NS1.2a |
| Q40539730 | Early activation of natural killer and B cells in response to primary dengue virus infection in A/J mice |
| Q34785824 | Elevated dengue virus nonstructural protein 1 serum levels and altered toll-like receptor 4 expression, nitric oxide, and tumor necrosis factor alpha production in dengue hemorrhagic Fever patients. |
| Q41034150 | Endothelial cell monolayers as a model system to investigate dengue shock syndrome |
| Q27486235 | Enhancement of the antibody response to flavivirus B-cell epitopes by using homologous or heterologous T-cell epitopes |
| Q27469571 | Establishment and characterization of Japanese encephalitis virus-specific, human CD4(+) T-cell clones: flavivirus cross-reactivity, protein recognition, and cytotoxic activity. |
| Q28204656 | Evasion of innate and adaptive immunity by flaviviruses |
| Q55519030 | Flavivirus serocomplex cross-reactive immunity is protective by activating heterologous memory CD4 T cells. |
| Q30857727 | Flaviviruses, an expanding threat in public health: focus on dengue, West Nile, and Japanese encephalitis virus |
| Q27478354 | Generation and Characterization of Monoclonal Antibodies against Dengue Virus Type 1 for Epitope Mapping and Serological Detection by Epitope-Based Peptide Antigens |
| Q27469896 | Human dendritic cells are activated by dengue virus infection: enhancement by gamma interferon and implications for disease pathogenesis |
| Q27480380 | Identification of amino acids involved in recognition by dengue virus NS3-specific, HLA-DR15-restricted cytotoxic CD4+ T-cell clones |
| Q27480325 | Identification of two epitopes on the dengue 4 virus capsid protein recognized by a serotype-specific and a panel of serotype-cross-reactive human CD4+ cytotoxic T-lymphocyte clones |
| Q37901360 | Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms |
| Q35613349 | Immunology and immunopathogenesis of dengue disease |
| Q40755086 | In VitroT-Cell Proliferative Response to the Flavivirus, West Nile |
| Q30373090 | In vitro evidence that commercial influenza vaccines are not similar in their ability to activate human T cell responses. |
| Q24813351 | Inducible nitric oxide synthase (iNOS) expression in monocytes during acute Dengue Fever in patients and during in vitro infection |
| Q42988555 | Induction of Japanese encephalitis virus-specific cytotoxic T lymphocytes in humans by poxvirus-based JE vaccine candidates |
| Q40597033 | Induction of T lymphocyte responses to dengue virus by a candidate tetravalent live attenuated dengue virus vaccine |
| Q34542855 | Innate and Adaptive Immune Responses Determine Protection against Disseminated Infection by West Nile Encephalitis Virus |
| Q36510607 | Interferon-dependent immunity is essential for resistance to primary dengue virus infection in mice, whereas T- and B-cell-dependent immunity are less critical |
| Q27472713 | Invasion and Maintenance of Dengue Virus Type 2 and Type 4 in the Americas |
| Q58999704 | Japanese Encephalitis Virus Generated Neurovirulence, Antigenicity, and Host Immune Responses |
| Q39461715 | Long-term memory cellular immune response to dengue virus after a natural primary infection |
| Q24570138 | Mechanisms of dengue virus-induced bone marrow suppression |
| Q27469591 | Modulation of Dengue virus infection in human cells by alpha, beta, and gamma interferons. |
| Q40685718 | Modulation of the functions of dengue virus-specific human CD8+ cytotoxic T cell clone by IL-2, IL-7 and IFN gamma |
| Q34684816 | Molecular mimicry of human endothelial cell antigen by autoantibodies to nonstructural protein 1 of dengue virus |
| Q27480738 | Multiple specificities in the murine CD4+ and CD8+ T-cell response to dengue virus |
| Q38098308 | New vaccines for neglected parasitic diseases and dengue |
| Q35613346 | Pathogenesis and pathophysiology of yellow fever |
| Q35613343 | Pathogenesis of flavivirus encephalitis |
| Q27486005 | Preferential usage of T-cell receptor V beta 17 by dengue virus-specific human T lymphocytes in a donor with immunity to dengue virus type 4 |
| Q34345965 | Primary vaccination with low dose live dengue 1 virus generates a proinflammatory, multifunctional T cell response in humans |
| Q43038243 | Proliferative Response of Human Peripheral Blood Mononuclear Cells to Japanese Encephalitis Virus |
| Q27485981 | Recognition of envelope protein by dengue virus serotype-specific human CD4+ CD8- cytotoxic T-cell clones |
| Q29619668 | Role of CD8+ T cells in control of West Nile virus infection |
| Q33336929 | Safety and immunogenicity of attenuated dengue virus vaccines (Aventis Pasteur) in human volunteers |
| Q64375183 | T Lymphocytes as Measurable Targets of Protection and Vaccination Against Viral Disorders |
| Q38631171 | T cell immunity to dengue virus and implications for vaccine design. |
| Q63246534 | T-Cell Response to Viral Hemorrhagic Fevers |
| Q35865841 | T-cell responses to dengue virus in humans |
| Q27486548 | T-helper cell and associated antibody response to synthetic peptides of the E glycoprotein of Murray Valley encephalitis virus |
| Q24616798 | The dengue viruses |
| Q91741475 | Two Is Better Than One: Evidence for T-Cell Cross-Protection Between Dengue and Zika and Implications on Vaccine Design |
| Q40647589 | Use of Epstein-Barr virus-transformed, autologous B-lymphoblastoid cells as antigen-presenting cells for establishment and maintenance of dengue virus-specific, human cytotoxic T lymphocyte clones |
Search more.